On April 4, 2023, James Clavijo, Chief Financial Officer of Longeveron Inc. provided notice to the Company of his intention to resign from his position with the Company, effective June 9, 2023. In connection with his departure, the parties intend that Mr. Clavijo will enter into a general release and separation agreement with the Company pursuant to which Mr. Clavijo will be eligible to receive certain severance benefits.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.03 USD | -0.96% | -3.74% | -92.43% |
03/06 | Longeveron Launches Contract Manufacturing Business | MT |
03/06 | Longeveron Inc. Announces Initiation of Work Under Its First Manufacturing Services Contract with Secretome Therapeutics | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-92.43% | 66.03L | |
+46.21% | 5.67TCr | |
-6.28% | 3.94TCr | |
+39.19% | 3.9TCr | |
-6.65% | 2.69TCr | |
+12.48% | 2.67TCr | |
-21.62% | 1.9TCr | |
-0.29% | 1.23TCr | |
+24.18% | 1.23TCr | |
+28.43% | 1.2TCr |
- Stock Market
- Equities
- LGVN Stock
- News Longeveron Inc.
- Longeveron Inc. Announces Resignation of James Clavijo as Chief Financial Officer, Effective June 9, 2023